BrightSpring Health Services, Inc.

NasdaqGS:BTSG Stock Report

Market Cap: US$8.6b

BrightSpring Health Services Valuation

Is BTSG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of BTSG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: BTSG ($41.34) is trading below our estimate of future cash flow value ($146.46)

Significantly Below Future Cash Flow Value: BTSG is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BTSG?

Key metric: As BTSG is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for BTSG. This is calculated by dividing BTSG's market cap by their current earnings.
What is BTSG's PE Ratio?
PE Ratio79.3x
EarningsUS$106.35m
Market CapUS$8.62b

Price to Earnings Ratio vs Peers

How does BTSG's PE Ratio compare to its peers?

The above table shows the PE ratio for BTSG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average44.6x
DVA DaVita
14x5.64%US$10.2b
CHE Chemed
20.8x9.51%US$5.6b
OPCH Option Care Health
22.3x11.97%US$4.6b
PRVA Privia Health Group
121.3x28.82%US$2.9b
BTSG BrightSpring Health Services
79.3x30.13%US$8.6b

Price-To-Earnings vs Peers: BTSG is expensive based on its Price-To-Earnings Ratio (79.3x) compared to the peer average (44.6x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does BTSG's PE Ratio compare vs other companies in the US Healthcare Industry?

5 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CYH Community Health Systems
0.9x-117.81%US$469.87m
NIVF NewGenIvf Group
0.07x44.27%US$1.19m
MDCE Medical Care Technologies
3.7xn/aUS$1.02m
IMTH AnTix Holdings
0.09xn/aUS$108.15k
BTSG 79.3xIndustry Avg. 22.3xNo. of Companies10PE01632486480+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: BTSG is expensive based on its Price-To-Earnings Ratio (79.3x) compared to the US Healthcare industry average (22.4x).

Price to Earnings Ratio vs Fair Ratio

What is BTSG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BTSG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio79.3x
Fair PE Ratio32.6x

Price-To-Earnings vs Fair Ratio: BTSG is expensive based on its Price-To-Earnings Ratio (79.3x) compared to the estimated Fair Price-To-Earnings Ratio (32.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BTSG forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$41.34
US$51.00
+23.37%
7.20%US$57.00US$41.00n/a15
Mar ’27US$41.43
US$47.33
+14.25%
11.25%US$55.00US$38.00n/a15
Feb ’27US$39.27
US$44.13
+12.38%
7.06%US$50.00US$38.00n/a15
Jan ’27US$37.45
US$41.93
+11.97%
6.99%US$50.00US$38.00n/a15
Dec ’26US$35.90
US$39.77
+10.78%
6.33%US$45.00US$34.00n/a13
Nov ’26US$33.05
US$38.25
+15.73%
9.96%US$45.00US$32.00n/a12
Oct ’26US$29.84
US$29.42
-1.42%
13.43%US$41.00US$25.00n/a12
Sep ’26US$23.69
US$28.71
+21.18%
14.28%US$41.00US$25.00n/a12
Aug ’26US$19.64
US$28.17
+43.41%
11.23%US$37.00US$25.00n/a12
Jul ’26US$22.27
US$28.10
+26.20%
11.33%US$37.00US$25.00n/a12
Jun ’26US$23.81
US$27.14
+13.97%
7.03%US$31.00US$25.00n/a11
May ’26US$17.90
US$24.41
+36.36%
11.75%US$30.00US$20.00n/a11
Apr ’26US$17.94
US$24.68
+37.58%
11.60%US$30.00US$20.00n/a11
Mar ’26US$19.28
US$24.68
+28.02%
11.60%US$30.00US$20.00US$41.4311
Feb ’26US$23.60
US$24.05
+1.89%
12.55%US$30.00US$20.00US$39.2711
Jan ’26US$17.03
US$22.17
+30.16%
7.78%US$27.00US$20.00US$37.4512
Dec ’25US$19.30
US$21.00
+8.81%
6.73%US$23.00US$19.00US$35.9011
Nov ’25US$17.25
US$18.59
+7.77%
14.63%US$23.00US$13.00US$33.0511
Oct ’25US$14.78
US$16.08
+8.82%
10.68%US$18.50US$13.00US$29.8412
Sep ’25US$12.55
US$15.83
+26.16%
10.34%US$18.50US$13.00US$23.6912
Aug ’25US$12.23
US$15.96
+30.49%
13.68%US$21.00US$13.00US$19.6412
Jul ’25US$10.96
US$15.96
+45.61%
13.68%US$21.00US$13.00US$22.2712
Jun ’25US$11.25
US$16.05
+42.63%
14.09%US$21.00US$13.00US$23.8111
May ’25US$10.66
US$15.68
+47.11%
18.65%US$23.00US$11.50US$17.9011
Apr ’25US$10.99
US$15.68
+42.69%
18.65%US$23.00US$11.50US$17.9411
Mar ’25US$8.95
US$16.25
+81.56%
22.75%US$26.00US$11.50US$19.2810
US$51
Fair Value
18.9% undervalued intrinsic discount
15
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/10 14:39
End of Day Share Price 2026/03/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BrightSpring Health Services, Inc. is covered by 20 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sean DodgeBMO Capital Markets Equity Research
Joanna Sylvia GajukBofA Global Research
David LarsenBTIG